Battery-free, smart contact lens delivers glaucoma drugs

Investigators from the Sun Yay-Sen University in Guangzhou have created a theranostic device that targets sensing rising fluid pressures within the eye to automatically deliver medication for a glaucoma patient.

Aerie doses first patient in phase 3 DED treatment study

The COMET-2 study is the first of three studies in the AR-15512 phase 3 registration program, with topline results expected by the second half of 2023.

Q&A: Pandemic's effect on dry eye patient numbers

Maria Sampalis, OD, continues her dry eye discussion what factors she considers when diagnosing and treating patients.